Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（ALTER0303）
Clinical trial NCT02388919 · COMPLETED
Trial details
- NCT number
- NCT02388919
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-26
- Primary completion
- 2017-01-05
- Enrollment
- 439
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.